πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 109 of 200 Β· A–Z by INN

  1. levodopa

    CORBILTA (PREVIOUSLY LEVODOPA/CARBIDOPA/ENTACAPONE SANDOZ) Amneal Pharma Europe Ltd

    ORAL FDA: approved Β· EMA: approved

    N04BA02
  2. levodopa + benserazide

    MADOPAR RAPID 62.5 Hoffmann-La Roche

    TGA: approved

  3. levodopa + carbidopa

    DUODOPA Alphapharm Pty Ltd

    TGA: approved

  4. levodopa + carbidopa + entacapone

    LECTEVA Lacuna Pharma Pty Ltd

    TGA: approved

  5. levofloxacin

    QUINSAIR Teva Pharma GmbH

    OPHTHALMIC FDA: approved Β· EMA: approved

    J01MA12
  6. levoketoconazole

    RECORLEV

    ORAL FDA: approved

  7. levoleucovorin

    KHAPZORY

    INTRAVENOUS FDA: approved

  8. levoleucovorin calcium

    FUSILEV Amneal Pharma Europe Ltd

    INTRAVENOUS FDA: approved

  9. levomepromazine

    LEVOPROME

    INJECTION FDA: approved

  10. levomethadyl acetate hydrochloride

    ORLAAM

    ORAL FDA: approved

  11. levomilnacipran

    LEVOMILNACIPRAN

    ORAL FDA: approved

  12. levomilnacipran hydrochloride

    LEVOMILNACIPRAN HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  13. levonordefrin

    MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN

    INJECTION FDA: approved

  14. levonorgestrel

    KYLEENA Lacuna Pharma Pty Ltd

    IMPLANTATION FDA: approved Β· TGA: approved

  15. levonorgestrel + ethinylestradiol

    TRIFEME 28 Pfizer Australia Pty Ltd

    TGA: approved

  16. levonorgestrel-releasing

    NMPA: clinical trials

  17. levopropoxyphene napsylate anhydrous

    NOVRAD

    ORAL FDA: approved

  18. levorphanol tartrate

    LEVO-DROMORAN

    INJECTION FDA: approved

  19. levothyroxine

    ELTROXIN Alphapharm Pty Ltd

    TGA: approved

  20. levothyroxine sodium

    LEVOTHYROXINE SODIUM MAIA Biotechnology

    ORAL FDA: approved

  21. lidocaine

    LIGNOCAINE INJECTION (BRIDGEWEST) Lacuna Pharma Pty Ltd

    TOPICAL FDA: approved Β· EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    N01BB20
  22. lidocaine hydrochloride

    LIDOCAINE HYDROCHLORIDE Regeneron Ireland Designated Activity Company (DAC)

    INTRADERMAL FDA: approved

  23. lidocaine hydrochloride, injectable

    NMPA: clinical trials

  24. lifileucel

    AMTAGVI Iovance Biotherapeutics B.V.

    EMA: application withdrawn

    L01XL11

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources